MKM downgrades Pfizer; “Neutral” Rating (PFE)
MKM Partners reported on Tuesday that they have downgraded global biopharmaceutical company, Pfizer Inc.(PFE).
The firm announced that they have downgraded the company from a “Buy” to “Neutral.” Analysts believe that PFE has few near-term catalysts and a weak pipeline.
Pfizer shares were mostly flat during premarket trading Tuesday. The stock is up 13.17% YTD.
The Bottom Line
Shares of Pfizer (PFE) have a 3.59% dividend yield, based on last night’s closing stock price of $24.49. We have been recommending shares of Pfizer (PFE) since Mar.2, 2012, when the stock was trading at $21.49.
Pfizer Inc.(PFE) is a “Recommended” dividend stock at this time, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars.
Get FREE Dividend Tips, Updates & MoreWe respect your privacy
- Powerful dividend insights sent every weekday morning
- Gain instant access to actionable investing tips
- Strategically grow your portfolio’s profitability